SCHILLER launches the new medilogFD Holter ECG device

19.11.2024

Now the time has come: we are officially launching the medilogFD. The medilogFD is the new SCHILLER 12-lead Holter ECG for a spatial heart health analysis. Find out more about the high-end features of this technical masterpiece here.

 

The 12-lead Holter ECG for a spatial heart health analysis allows assessing the full spectrum of cardiac ECG conditions. It instantly detects atrial fibrillation/atrial flutter based on true P-wave analysis. The optional SpO2 sensor provides additional respiratory information.

  • Regional assessment of myocardial ischemia in the dynamic setting of everyday life.
  • Identify the origin of ectopic beats, whether they are from the left or right ventricle.
  • Superior in identifying abnormal heartbeats that start in the right or left atrium.
  • Superior resting ECG-grade 128,000Hz sampling rate on 12 leads for real-time P-wave analysis, sophisticated artifact suppression, and motion detection, enabling a speedy evaluation
  • Instantaneous detection of atrial fibrillation
  • Analysis of respiratory episodes
  • High-resolution heart rate variability (HRV)
  • Colour display with real-time ECG preview
  • Internal rechargeable battery plus AAA batteries for up to 5 days of monitoring
  • Completes the medilog line-up with medilogAR (3-lead Holter ECG, up to 14 days runtime) and medilog DARWIN2 (high-end ECG analysis software)

These are just a few of the many possibilities of the medilogFD. You can find much more in the product brochure and in the medilogFD video.

Learn more about medilogFD and watch the video.

This content is displayed to you via YouTube.
This allows YouTube to collect personal data. You can find details on this in YouTube's terms of use.

Links


News & Events